November 2012

NEWS For more information: Cathy Yarbrough press@ashg.org Embargo: 4:30 p.m. PT, Thursday, Nov. 8, 2012 A consortium of scientists who are taking a novel approach in their research to detect the genetic variations that predispose individuals to type 2 diabetes provided an update of their findings at the American Society of Human Genetics (ASHG) 2012... Read More

NEWS For more information: Cathy Yarbrough press@ashg.org Embargo: 10:30 a.m. PT, Thursday, Nov. 8, 2012 About 10.6% of the inherited genetic risk for developing coronary artery disease (CAD) can be explained by specific DNA variations, according to research reported today at the American Society of Human Genetics 2012 meeting. The research, conducted by scientists in... Read More

NEWS For more information: Cathy Yarbrough press@ashg.org 858-243-1814 Embargo: 10:30 a.m. PT, Thursday, Nov. 8, 2012 Research findings confirming that de novo mutations represent a major cause of previously unexplained intellectual disability were presented today (Nov. 8) at the American Society of Human Genetics 2012 meeting in San Francisco. Josep de Ligt, M.Sc., bioinformatician and... Read More

NEWS For more information: Cathy Yarbrough press@ashg.org 858-243-1814 Embargo: 10:30 a.m. PT, Thursday, Nov. 8, 2012 Next generation sequencing of the exome, the 1 to 2% of the DNA containing the genes that code for proteins, enabled the identification of the likely genetic causes of unexplained forms of intellectual disability in over 30% of a... Read More

NEWS For more information: Cathy Yarbrough press@ashg.org 858-243-1814 Embargo: 4:30 p.m. PT, Tuesday, Nov. 6, 2012 A presentation at the American Society of Human Genetics 2012 meeting today (Nov. 6) updated genetics experts about a one-year-old research initiative that brought together researchers, clinicians and policy experts to tackle the challenges of incorporating new genomic technologies... Read More